@article{11b635657c2041a681de31ddac67d684,
title = "The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience",
author = "P. Jain and H. Kantarjian and F. Ravandi and Thomas, \{Deborah A\} and Susan O'Brien and T. Kadia and J. Burger and G. Borthakur and N. Daver and E. Jabbour and Marina Konopleva and Cortes, \{Jorge E\} and N. Pemmaraju and Kelly, \{M. A.\} and M. Cardenas-Turanzas and R. Garris and Faderl, \{Stefan H\}",
note = "Funding Information: This study was supported partly by GlaxoSmithKline Pharmaceuticals (to SF).",
year = "2014",
month = apr,
doi = "10.1038/leu.2013.312",
language = "English (US)",
volume = "28",
pages = "973--975",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "4",
}